To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Lords Chamber - Tue 20 Jul 2021
Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021

"My Lords, I declare an interest as an adviser to Future Planet Capital, a sustainable investment firm that has a stake in Vaccitech, the start-up that licensed the intellectual property and original R&D relating to what is known as the AstraZeneca vaccine, of which I have received two doses. I …..."
Lord Wei - View Speech

View all Lord Wei (Con - Life peer) contributions to the debate on: Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021
Written Question
Trikafta
Monday 15th February 2021

Asked by: Lord Wei (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government whether Kaftrio is available to cystic fibrosis patients in England; if not, why not; if it is available to such patients, whether there are any restrictions on that drug's availability; and if so, why.

Answered by Lord Bethell

Kaftrio is available to National Health Service patients in England in line with its license through an interim access deal negotiated between NHS England and NHS Improvement and Vertex, the drug manufacturer. This deal will last for four years and means that eligible NHS patients are among the first in Europe to benefit from access to Kaftrio.

As part of this deal, NHS England and NHS Improvement committed to expanding patient access to Kaftrio to cover any future license extensions by the European Medicines Agency.

Speech in Lords Chamber - Fri 24 Jul 2020
Health Protection (Coronavirus, Restrictions) (No. 2) (England) Regulations 2020

"My Lords, I declare my interests and pay tribute to my noble friend Lord Bethell. It is not easy being a Minister in this situation, and he has been weathering it with great gravitas and perseverance.

I have just one question. Rather than arguing about masks, which are an important …..."
Lord Wei - View Speech

View all Lord Wei (Con - Life peer) contributions to the debate on: Health Protection (Coronavirus, Restrictions) (No. 2) (England) Regulations 2020
Speech in Lords Chamber - Tue 12 May 2020
Health Protection (Coronavirus, Restrictions) (England) Regulations 2020

"My Lords, I want to sort of start my comments by congratulating the Government and the police on showing incredible restraint in acting under huge pressure in what has been an incredibly difficult period. The amendments to these regulations are welcome because they start to allow people to get more …..."
Lord Wei - View Speech

View all Lord Wei (Con - Life peer) contributions to the debate on: Health Protection (Coronavirus, Restrictions) (England) Regulations 2020
Speech in Lords Chamber - Thu 23 Apr 2020
Covid-19: Social Care Services

"My Lords, I thank the noble Baroness, Lady Wheeler, for tabling this very timely debate, and I declare my interests on the Lords register. I, too, echo the praise that others have expressed for the Government and our heroic NHS and care workers, especially those on the front line.

I …..."
Lord Wei - View Speech

View all Lord Wei (Con - Life peer) contributions to the debate on: Covid-19: Social Care Services
Speech in Lords Chamber - Thu 17 Oct 2013
Ageing: Public Services and Demographic Change Committee Report

"My Lords, it is a great honour and pleasure to follow my noble friend Lord Livingston of Parkhead’s insightful, witty and passionate maiden speech. We all welcome his contribution to the House, and indeed to the whole country and beyond. As a businessman, he distinguished himself when running BT, not …..."
Lord Wei - View Speech

View all Lord Wei (Con - Life peer) contributions to the debate on: Ageing: Public Services and Demographic Change Committee Report